| Year |
Citation |
Score |
| 2021 |
Stark LE, Guan W, Colvin ME, LiWang PJ. The binding and specificity of chemokine binding proteins, through the lens of experiment and computation. Biomedical Journal. PMID 34311129 DOI: 10.1016/j.bj.2021.07.004 |
0.339 |
|
| 2020 |
Stark LE, LiWang P, Colvin ME. Determining Factors that Influence vCCI Loop Interactions in vCCI-Chemokine Binding through MD Simulation Biophysical Journal. 118. DOI: 10.1016/J.Bpj.2019.11.2792 |
0.333 |
|
| 2019 |
Fischer K, Nguyen K, LiWang PJ. Griffithsin retains anti-HIV-1 potency with changes in gp120 glycosylation and complements broadly neutralizing antibodies PGT121 and PGT126. Antimicrobial Agents and Chemotherapy. PMID 31611356 DOI: 10.1128/Aac.01084-19 |
0.381 |
|
| 2019 |
Yavuz B, Morgan JL, Herrera C, Harrington K, Perez-Ramirez B, LiWang PJ, Kaplan DL. Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention. Journal of Controlled Release : Official Journal of the Controlled Release Society. 301: 1-12. PMID 30876951 DOI: 10.1016/J.Jconrel.2019.03.001 |
0.329 |
|
| 2018 |
Stark LE, LiWang PJ, Colvin ME. Evaluating Protein - Protein Interactions in Chemokine - Inhibitor Complexes using MD Simulation Biophysical Journal. 114. DOI: 10.1016/J.Bpj.2017.11.394 |
0.302 |
|
| 2017 |
Nguyen AF, Kuo NW, Showalter LJ, Ramos R, Dupureur CM, Colvin ME, LiWang PJ. Biophysical and Computational Studies of the vCCI:vMIP-II Complex. International Journal of Molecular Sciences. 18. PMID 28813018 DOI: 10.3390/Ijms18081778 |
0.409 |
|
| 2017 |
Zhang L, Herrera C, Coburn J, Olejniczak N, Ziprin P, Kaplan DL, LiWang PJ. Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks Acs Biomaterials Science & Engineering. 3: 1654-1665. DOI: 10.1021/Acsbiomaterials.7B00167 |
0.366 |
|
| 2014 |
Zhang L, LiWang PJ. Chemokine-receptor interactions: solving the puzzle, piece by piece. Structure (London, England : 1993). 22: 1550-2. PMID 25438668 DOI: 10.1016/J.Str.2014.10.004 |
0.312 |
|
| 2014 |
Kuo NW, Gao YG, Schill MS, Isern N, Dupureur CM, Liwang PJ. Structural insights into the interaction between a potent anti-inflammatory protein, viral CC chemokine inhibitor (vCCI), and the human CC chemokine, Eotaxin-1. The Journal of Biological Chemistry. 289: 6592-603. PMID 24482230 DOI: 10.1074/Jbc.M113.538991 |
0.438 |
|
| 2013 |
Xue J, Hoorelbeke B, Kagiampakis I, Demeler B, Balzarini J, Liwang PJ. The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism. Antimicrobial Agents and Chemotherapy. 57: 3976-89. PMID 23752505 DOI: 10.1128/Aac.00332-13 |
0.474 |
|
| 2013 |
Hoorelbeke B, Xue J, LiWang PJ, Balzarini J. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1. Plos One. 8: e64132. PMID 23741304 DOI: 10.1371/Journal.Pone.0064132 |
0.412 |
|
| 2013 |
Hoorelbeke B, van Montfort T, Xue J, LiWang PJ, Tanaka H, Igarashi Y, Van Damme EJ, Sanders RW, Balzarini J. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120. Febs Letters. 587: 860-6. PMID 23454641 DOI: 10.1016/J.Febslet.2013.02.037 |
0.406 |
|
| 2012 |
Xue J, Gao Y, Hoorelbeke B, Kagiampakis I, Zhao B, Demeler B, Balzarini J, Liwang PJ. The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin. Molecular Pharmaceutics. 9: 2613-25. PMID 22827601 DOI: 10.1021/Mp300194B |
0.453 |
|
| 2011 |
Zhao B, Mankowski MK, Snyder BA, Ptak RG, Liwang PJ. Highly potent chimeric inhibitors targeting two steps of HIV cell entry. The Journal of Biological Chemistry. 286: 28370-81. PMID 21659523 DOI: 10.1074/Jbc.M111.234799 |
0.374 |
|
| 2011 |
Kagiampakis I, Gharibi A, Mankowski MK, Snyder BA, Ptak RG, Alatas K, LiWang PJ. Potent strategy to inhibit HIV-1 by binding both gp120 and gp41. Antimicrobial Agents and Chemotherapy. 55: 264-75. PMID 20956603 DOI: 10.1128/Aac.00376-10 |
0.42 |
|
| 2010 |
Zhao B, Liwang PJ. Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans. Biochemistry. 49: 7012-22. PMID 20712376 DOI: 10.1021/Bi100549Y |
0.429 |
|
| 2010 |
Jin H, Kagiampakis I, Li P, Liwang PJ. Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES. Proteins. 78: 295-308. PMID 19722264 DOI: 10.1002/Prot.22542 |
0.425 |
|
| 2009 |
Jin H, Siwak EB, Smith R, Liwang PJ. WITHDRAWN: Very strong synergy between modified RANTES and gp41 binding peptides leads to potent anti-HIV-1 activity. Antimicrobial Agents and Chemotherapy. PMID 18663025 DOI: 10.1128/Aac.01250-07 |
0.375 |
|
| 2008 |
Kagiampakis I, Jin H, Kim S, Vannucci M, LiWang PJ, Tsai J. Conservation of unfavorable sequence motifs that contribute to the chemokine quaternary state. Biochemistry. 47: 10637-48. PMID 18781776 DOI: 10.1021/Bi702288A |
0.347 |
|
| 2007 |
Jin H, Shen X, Baggett BR, Kong X, LiWang PJ. The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor. The Journal of Biological Chemistry. 282: 27976-83. PMID 17644519 DOI: 10.1074/Jbc.M702654200 |
0.428 |
|
| 2006 |
Zhang L, Derider M, McCornack MA, Jao SC, Isern N, Ness T, Moyer R, LiWang PJ. Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta. Proceedings of the National Academy of Sciences of the United States of America. 103: 13985-90. PMID 16963564 DOI: 10.1073/Pnas.0602142103 |
0.451 |
|
| 2005 |
Jin H, Hayes GL, Darbha NS, Meyer E, LiWang PJ. Investigation of CC and CXC chemokine quaternary state mutants. Biochemical and Biophysical Research Communications. 338: 987-99. PMID 16256937 DOI: 10.1016/J.Bbrc.2005.10.062 |
0.336 |
|
| 2005 |
Casarosa P, Waldhoer M, LiWang PJ, Vischer HF, Kledal T, Timmerman H, Schwartz TW, Smit MJ, Leurs R. CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor. The Journal of Biological Chemistry. 280: 3275-85. PMID 15546882 DOI: 10.1074/Jbc.M407536200 |
0.391 |
|
| 2004 |
McCornack MA, Boren DM, LiWang PJ. Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta. Biochemistry. 43: 10090-101. PMID 15287737 DOI: 10.1021/Bi049751U |
0.408 |
|
| 2003 |
Zhang Y, Lu H, LiWang P, Sili U, Templeton NS. Optimization of gene expression in nonactivated circulating lymphocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 629-36. PMID 14529836 DOI: 10.1016/S1525-0016(03)00231-4 |
0.312 |
|
| 2003 |
Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, Borlat F, Wells TN, Kosco-Vilbois MH. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proceedings of the National Academy of Sciences of the United States of America. 100: 1885-90. PMID 12571364 DOI: 10.1073/Pnas.0334864100 |
0.331 |
|
| 2003 |
McCornack MA, Cassidy CK, LiWang PJ. The binding surface and affinity of monomeric and dimeric chemokine macrophage inflammatory protein 1 beta for various glycosaminoglycan disaccharides. The Journal of Biological Chemistry. 278: 1946-56. PMID 12411442 DOI: 10.1074/Jbc.M207440200 |
0.451 |
|
| 2002 |
Bondue A, Jao SC, Blanpain C, Parmentier M, LiWang PJ. Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding. Biochemistry. 41: 13548-55. PMID 12427015 DOI: 10.1021/Bi026087D |
0.459 |
|
| 2001 |
Kim S, Jao SC, Laurence JS, LiWang PJ. Structural comparison of monomeric variants of the chemokine MIP-1β having differing ability to bind the receptor CCR5 Biochemistry. 40: 10782-10791. PMID 11535053 DOI: 10.1021/Bi011065X |
0.437 |
|
| 2001 |
Laurence JS, Blanpain C, De Leener A, Parmentier M, LiWang PJ. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions. Biochemistry. 40: 4990-9. PMID 11305915 DOI: 10.1021/Bi002593W |
0.451 |
|
| 2000 |
Laurence JS, Blanpain C, Burgner JW, Parmentier M, LiWang PJ. CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding. Biochemistry. 39: 3401-9. PMID 10727234 DOI: 10.1021/Bi9923196 |
0.438 |
|
| 1999 |
Liwang AC, Wang ZX, Sun Y, Peiper SC, LiWang PJ. The solution structure of the anti-HIV chemokine vMIP-II Protein Science. 8: 2270-2280. PMID 10595530 DOI: 10.1110/Ps.8.11.2270 |
0.447 |
|
| 1999 |
LiWang AC, Cao JJ, Zheng H, Lu Z, Peiper SC, LiWang PJ. Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory protein-II (VMIP-II) reveals a fully monomeric protein Biochemistry. 38: 442-453. PMID 9890927 DOI: 10.1021/Bi9812726 |
0.432 |
|
| 1998 |
Laurence JS, LiWang AC, LiWang PJ. Effect of N-terminal truncation and solution conditions on chemokine dimer stability: Nuclear magnetic resonance structural analysis of macrophage inflammatory protein 1β mutants Biochemistry. 37: 9346-9354. PMID 9649315 DOI: 10.1021/Bi980329L |
0.437 |
|
| Show low-probability matches. |